Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2018  |  Volume : 31  |  Issue : 3  |  Page : 780-785

Serum level of surfactant protein-D and its genetic polymorphisms in chronic obstructive pulmonary disease patients


Department of Biochemistry, Faculty of Medicine, Menoufia University, Shebin Elkom, Egypt

Correspondence Address:
Manal A Ellaithy
Department of Biochemistry, Faculty of Medicine, Menoufia University, Shebin Elkom
Egypt
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mmj.mmj_406_17

Rights and Permissions

Objective The aim of this study was to study the serum level of surfactant protein-D (SP-D) and its genetic polymorphisms in chronic obstructive pulmonary disease (COPD) patients and its relation with severity. Background SP-D plays a role in COPD progression. It contributed toward the inflammatory response in the lungs. Single nucleotide polymorphisms of the surfactant protein-D gene (SFPTD) are believed to be associated with the risk of COPD. Patients and methods A case–control study was carried out on 76 individuals: group I included 50 patients with COPD and group II included 26 age-matched and sex-matched apparently healthy individuals. All participants were subjected to an assessment of history, clinical examination, BMI estimation, spirometry, serum SP-D by enzyme-linked immunosorbent assay, and genotyping of single nucleotide polymorphisms of SFPTD gene (rs721917, rs3088308) using the TaqMan allelic discrimination assay by real time PCR. Results Serum SP-D was significantly higher in patients than controls. The CT genotype of rs721719 was significantly more prevalent in patients. The T allele of both rs3088308 and rs721917 and smoking index were associated with increased SP-D levels. The T allele of rs721917 was associated with the risk of COPD. There was a significant difference between different genotypes of rs721917 in forced expiratory volume in 1 s (FEV1), forced volume capacity (FVC), FEV1/FVC, and serum SP-D. Conclusion SP-D can be used as a biomarker of the severity of COPD. The T allele of rs721917 might be a susceptible gene for COPD. The T allele of rs3088308 was associated with elevated serum SP-D, but not with COPD.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1591    
    Printed55    
    Emailed0    
    PDF Downloaded94    
    Comments [Add]    

Recommend this journal